International Clinical Trial: Mechanism and Application Research on Treating Type 2 Diabetes by Reprogramming the Gut-Brain Axis through Duodenal Mucosa Ablation Usin

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119439) titled 'Mechanism and Application Research on Treating Type 2 Diabetes by Reprogramming the Gut-Brain Axis through Duodenal Mucosa Ablation Usin' on Feb. 27.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: NanJing First Hospital

Condition: Type 2 Diabetes Mellitus

Intervention: T2DM group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: T2DM group:40;Healthy control group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=311275

Published by HT Digital Content S...